Prenatal detection of major congenital heart disease - optimising resources to improve outcomes

Siobhan Corcoran1, Kaleigh Briggs2, Hugh O' Connor1

  • 1Royal College of Surgeons in Ireland, Department of Obstetrics and Gynaecology, Rotunda Hospital, Dublin, Ireland.

Insights

Prenatal screening for congenital heart disease (CHD) significantly improved detection rates from 31% to 91% after protocol changes. This enhancement is crucial for early intervention in major fetal heart abnormalities.

Area of Science:

  • Cardiology
  • Prenatal Diagnosis
  • Public Health

Background:

  • Congenital heart disease (CHD) is the most common major structural fetal abnormality.
  • Prenatal detection of CHD offers significant benefits for management and outcomes.
  • A single national center for pediatric cardiothoracic surgery facilitates comprehensive case ascertainment in Ireland.

Purpose of the Study:

  • To evaluate the precision of prenatal diagnosis for CHD before and after implementing a new screening protocol.
  • To assess the impact of extended cardiac views, mandatory recalls, and a multidisciplinary Fetal Cardiac clinic on detection rates.

Main Methods:

  • Analysis of surgery records from the National Children's Cardiac Centre for major congenital heart defects requiring surgical intervention in the first six months of life.
  • Exclusion of minor procedures like patent ductus arteriosus ligation and isolated atrial septal defect repairs.
  • Review of the Fetal Medicine database and perinatal pathology mortality data, utilizing the Cochrane-Armitage trend test for statistical significance.

Main Results:

  • The incidence of major CHD was 0.5% (238/51,822) during the study period.
  • Prenatal detection rates for major CHD increased significantly from 31% to 91% (p<0.001).
  • Detection rates for critical duct-dependent lesions improved from 19% to 100%.

Conclusions:

  • Multifaceted changes in the prenatal screening protocol led to a dramatic improvement in CHD detection rates.
  • Replication of this prenatal program at local levels is essential for improving detection in geographically remote areas.
  • Enhanced prenatal diagnosis facilitates timely intervention for major congenital heart defects.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
636
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
591
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
416